Showing results (71-80 of 98) with videos related to

Sort By:
Pageof 10
Frontiers in Immunology|April 24, 2023
Rapid and sustained T cell-based immunotherapy against invasive fungal disease via a combined two step procedureSabine Tischer-Zimmermann, Elisabeth Salzer, Tamires Bitencourt, et al.
American Journal of Cancer Research|October 18, 2021
Asciminib and ponatinib exert synergistic anti-neoplastic effects on CML cells expressing <i>BCR-ABL1</i> <sup>T315I</sup>-compound mutationsKaroline V Gleixner, Yüksel Filik, Daniela Berger, et al.
Scientific Reports|October 14, 2025
Scaled-up non-thermal plasma-generating device Plasmatico enables effective and harmless disinfection of personal protective equipmentEva Vaňková, Klára Obrová, Jan Hodek, et al.
Memo|April 15, 2020
Development of treatment and clinical results in childhood AML in Austria (1993-2013)Heidrun Boztug, Nora Mühlegger, Evgenia Glogova, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 19, 2006
Mixed lineage leukemia-rearranged childhood pro-B and CD10-negative pre-B acute lymphoblastic leukemia constitute a distinct clinical entityAndishe Attarbaschi, Georg Mann, Margit König, et al.
Hematological Oncology|June 28, 2020
Illuminating novel biological aspects and potential new therapeutic approaches for chronic myeloproliferative malignanciesTariq I Mughal, Naveen Pemmaraju, Bethan Psaila, et al.
Plos Pathogens|November 2, 2023
Proline catabolism is a key factor facilitating Candida albicans pathogenicityFitz Gerald S Silao, Tong Jiang, Biborka Bereczky-Veress, et al.
Ebiomedicine|July 12, 2024
Combination cell therapy leads to clonal deletion of donor-specific T cells in kidney transplant recipientsAna F David, Andreas Heinzel, Michael Kammer, et al.
Wiener Klinische Wochenschrift|August 3, 2023
Prospective use of molecular minimal residual disease for risk stratification in children and adolescents with acute lymphoblastic leukemia : Long-term results of the AIEOP-BFM ALL 2000 trial in AustriaLeila Ronceray, Michael Dworzak, Karin Dieckmann, et al.
Haematologica|April 19, 2012
High-dose imatinib induction followed by standard-dose maintenance in pre-treated chronic phase chronic myeloid leukemia patients--final analysis of a randomized, multicenter, phase III trialAndreas L Petzer, Dominic Fong, Thomas Lion, et al.
Pageof 10